 |
5,5′,5″-[Phosphinothioylidyne-tris(imino-2,1-ethanediyl)]tris[5-methylchelidoninium]trihydroide hexahydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2003-08-20 00:00:00 |
| Sponsor | Now Pharm AG;241, route d'Arlon, L-1150; |
